Beauty Health Co
NASDAQ:SKIN

Watchlist Manager
Beauty Health Co Logo
Beauty Health Co
NASDAQ:SKIN
Watchlist
Price: 1.43 USD -0.69% Market Closed
Market Cap: 182.3m USD

Wall Street
Price Targets

SKIN Price Targets Summary
Beauty Health Co

Wall Street analysts forecast SKIN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SKIN is 1.97 USD with a low forecast of 1.52 USD and a high forecast of 3.68 USD.

Lowest
Price Target
1.52 USD
6% Upside
Average
Price Target
1.97 USD
38% Upside
Highest
Price Target
3.68 USD
157% Upside
Beauty Health Co Competitors:
Price Targets
ITP
Interparfums SA
37% Upside
600315
Shanghai Jahwa United Co Ltd
10% Upside
4922
Kose Corp
15% Upside
ULVR
Unilever PLC
12% Upside
4931
Shinnihonseiyaku Co Ltd
24% Upside
BEI
Beiersdorf AG
26% Upside
4928
Noevir Holdings Co Ltd
7% Upside
NATR
Natures Sunshine Products Inc
6% Upside

Revenue
Forecast

Revenue Estimate
Beauty Health Co

For the last 4 years the compound annual growth rate for Beauty Health Co's revenue is 29%. The projected CAGR for the next 4 years is 1%.

29%
Past Growth
1%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Beauty Health Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Net Income
Forecast

Net Income Estimate
Beauty Health Co

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
48%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SKIN's stock price target?
Price Target
1.97 USD

According to Wall Street analysts, the average 1-year price target for SKIN is 1.97 USD with a low forecast of 1.52 USD and a high forecast of 3.68 USD.

What is Beauty Health Co's Revenue forecast?
Projected CAGR
1%

For the last 4 years the compound annual growth rate for Beauty Health Co's revenue is 29%. The projected CAGR for the next 4 years is 1%.

Back to Top